International Clinical Trial: Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Infusion Chemotherapy (HAIC) as Adjuvant Therapy After Radical Resection of Extrahepatic Biliary Tract Cancer

Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134161) titled 'Prospective, Single-Arm Clinical Study on the Efficacy and Safety of Hepatic Artery Infusion Chemotherapy (HAIC) as Adjuvant Therapy After Radical Resection of Extrahepatic Biliary Tract Cancer' on Oct. 11.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: The First Affiliated Hospital of Zhengzhou University

Condition: Extrahepatic Biliary Tract Cancer

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-06-24

Target Sample Size: Observation group:40;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=29272...